Passage Bio, Inc. (PASG) financial statements and ratios from SEC XBRL: revenue $343000.00 (TTM), net margin -54048.4%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $343000.00 |
| Net Margin | -54048.4% |
| Price / Book | 3.16 |
| Sector P/E (Healthcare) | 21.7 |
PASG overview · PASG earnings · PASG KPIs · PASG investor relations · PASG ownership · PASG peers · PASG filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.